CRISPRBITS Pvt Ltd

Startup
Summarized by Halo AI

CrisprBits is a biotechnology firm that develops CRISPR-based intelligent molecular platforms for healthcare, diagnostics, and synthetic biology, aiming to provide scalable and affordable solutions for disease detection and genome engineering.

Founded & HQ
Bengaluru, Karnataka, India
Company size
11-50 employees
Funding
~$3.3M
IP status
3 patents filed
Activity highlights
Secured 3 million USD in Pre-Series A funding led by Spectrum Impact to commercialize its PathCrisp molecular diagnostics platform

CrisprBits is a biotechnology company that builds CRISPR-powered intelligent molecular platforms and solutions designed to provide scalable, affordable innovations across healthcare, food safety, and environmental sectors. Their core technological offerings include PathCrisp for rapid point-of-need molecular diagnostics, EdiCrisp for precision gene editing, and CurieCrisp, a disease modeling platform for preclinical testing and therapeutics development. The company leverages synthetic biology to address diverse challenges, ranging from disease detection and sustainable agriculture to microbial strain engineering and industrial bioproduction. Founded in 2020 by a team of experts with backgrounds from BITS Pilani, the company operates with offices in Delhi and a laboratory in Bengaluru, aiming to democratize CRISPR technology for widespread application.

These platforms provide significant value to partners and customers in the pharmaceutical and life sciences industries by enabling faster, more accurate, and cost-effective research and diagnostic outcomes. By focusing on modular, customizable solutions, CrisprBits facilitates early intervention for drug-resistant infections and supports the development of personalized treatments for rare genetic diseases. Their impact extends to ensuring food safety through pathogen detection and promoting environmental resilience via advanced microbial engineering. Supported by institutional investors and strategic partnerships, including incubation at C-CAMP, the company continues to advance its scientific mission through collaborative research and the development of impactful biotechnology products."},field_source_urls:[{field:

AI summary generated on Jun 22, 2026
OpenAlexOpenAlex

For general inquiries

NM
Nivedita Madduri
Application Specialist
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.